TOKYO -- Fujifilm Holdings announced Tuesday the start of a clinical trial for its flu-fighting drug Avigan to treat COVID-19, in which it will be administered to about 100 patients in Japanese hospitals to gauge safety and efficacy.
Pharmaceuticals
Fujifilm starts clinical trial on Avigan for coronavirus
Company also says it is ready to ramp up production of the anti-flu medication
Tablets of Avigan shown in 2014. The anti-flu drug, made by a Fujifilm unit, is now in the spotlight as a possible coronavirus treatment © Reuters
Read Next
Latest on Pharmaceuticals
